CN112903882A - 一种保元汤制剂的hplc特征图谱及其构建方法 - Google Patents
一种保元汤制剂的hplc特征图谱及其构建方法 Download PDFInfo
- Publication number
- CN112903882A CN112903882A CN202110140726.5A CN202110140726A CN112903882A CN 112903882 A CN112903882 A CN 112903882A CN 202110140726 A CN202110140726 A CN 202110140726A CN 112903882 A CN112903882 A CN 112903882A
- Authority
- CN
- China
- Prior art keywords
- peak
- mobile phase
- chromatographic
- peaks
- hplc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 40
- 238000004128 high performance liquid chromatography Methods 0.000 title claims abstract description 29
- 238000001228 spectrum Methods 0.000 title claims abstract description 18
- 238000010276 construction Methods 0.000 title abstract description 6
- 238000000034 method Methods 0.000 claims abstract description 35
- 239000012488 sample solution Substances 0.000 claims abstract description 24
- 239000013558 reference substance Substances 0.000 claims abstract description 10
- ZZAJQOPSWWVMBI-UHFFFAOYSA-N Calycosin Natural products C1=C(O)C(OC)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZZAJQOPSWWVMBI-UHFFFAOYSA-N 0.000 claims description 24
- 239000000243 solution Substances 0.000 claims description 24
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 claims description 19
- GSZUGBAEBARHAW-UHFFFAOYSA-N sophoraflavone B Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C=2OC3=CC(O)=CC=C3C(=O)C=2)C=C1 GSZUGBAEBARHAW-UHFFFAOYSA-N 0.000 claims description 18
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 15
- UFNDONGOJKNAES-UHFFFAOYSA-N Ginsenoside Rb1 Natural products CC(=CCCC(C)(OC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CC(O)C45C)C UFNDONGOJKNAES-UHFFFAOYSA-N 0.000 claims description 15
- GZYPWOGIYAIIPV-JBDTYSNRSA-N ginsenoside Rb1 Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)O[C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GZYPWOGIYAIIPV-JBDTYSNRSA-N 0.000 claims description 15
- TXEWRVNOAJOINC-UHFFFAOYSA-N ginsenoside Rb2 Natural products CC(=CCCC(OC1OC(COC2OCC(O)C(O)C2O)C(O)C(O)C1O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CCC45C)C TXEWRVNOAJOINC-UHFFFAOYSA-N 0.000 claims description 15
- 230000014759 maintenance of location Effects 0.000 claims description 15
- -1 calycosin glucoside Chemical class 0.000 claims description 14
- 229930182478 glucoside Natural products 0.000 claims description 14
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 14
- KSDSYIXRWHRPMN-UHFFFAOYSA-N 4'-O-beta-D-Galactopyranoside-6''-p-Coumaroylprunin-4',5,7-Trihydroxyflavanone Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC(O)=C3C(=O)C2)C=C1 KSDSYIXRWHRPMN-UHFFFAOYSA-N 0.000 claims description 13
- DEMKZLAVQYISIA-ONJCETCRSA-N Liquiritin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)c1ccc([C@@H]2Oc3c(C(=O)C2)ccc(O)c3)cc1 DEMKZLAVQYISIA-ONJCETCRSA-N 0.000 claims description 13
- DEMKZLAVQYISIA-UHFFFAOYSA-N Liquirtin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-UHFFFAOYSA-N 0.000 claims description 13
- DEMKZLAVQYISIA-ZRWXNEIDSA-N liquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C([C@H]2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-ZRWXNEIDSA-N 0.000 claims description 13
- 238000001514 detection method Methods 0.000 claims description 12
- 244000303040 Glycyrrhiza glabra Species 0.000 claims description 11
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 11
- 235000006886 Zingiber officinale Nutrition 0.000 claims description 11
- 235000008397 ginger Nutrition 0.000 claims description 11
- 239000000463 material Substances 0.000 claims description 11
- 244000223760 Cinnamomum zeylanicum Species 0.000 claims description 10
- YNWXJFQOCHMPCK-UHFFFAOYSA-N Isoliquiritin Natural products OC1C(O)C(O)C(CO)OC1OC(C=C1)=CC=C1C=CC(=O)C1=CC=C(O)C=C1O YNWXJFQOCHMPCK-UHFFFAOYSA-N 0.000 claims description 10
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 10
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 10
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 10
- 235000017803 cinnamon Nutrition 0.000 claims description 10
- HKQYGTCOTHHOMP-UHFFFAOYSA-N formononetin Chemical group C1=CC(OC)=CC=C1C1=COC2=CC(O)=CC=C2C1=O HKQYGTCOTHHOMP-UHFFFAOYSA-N 0.000 claims description 10
- 235000008434 ginseng Nutrition 0.000 claims description 10
- YNWXJFQOCHMPCK-LXGDFETPSA-N isoliquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C=C1)=CC=C1\C=C\C(=O)C1=CC=C(O)C=C1O YNWXJFQOCHMPCK-LXGDFETPSA-N 0.000 claims description 10
- YURJSTAIMNSZAE-UHFFFAOYSA-N UNPD89172 Natural products C1CC(C2(CC(C3C(C)(C)C(O)CCC3(C)C2CC2O)OC3C(C(O)C(O)C(CO)O3)O)C)(C)C2C1C(C)(CCC=C(C)C)OC1OC(CO)C(O)C(O)C1O YURJSTAIMNSZAE-UHFFFAOYSA-N 0.000 claims description 9
- PWAOOJDMFUQOKB-WCZZMFLVSA-N ginsenoside Re Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@@H]2[C@H]3C(C)(C)[C@@H](O)CC[C@]3(C)[C@@H]3[C@@]([C@@]4(CC[C@@H]([C@H]4[C@H](O)C3)[C@](C)(CCC=C(C)C)O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C)(C)C2)O[C@H](CO)[C@@H](O)[C@@H]1O PWAOOJDMFUQOKB-WCZZMFLVSA-N 0.000 claims description 9
- YURJSTAIMNSZAE-HHNZYBFYSA-N ginsenoside Rg1 Chemical compound O([C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(C[C@@H]([C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3C[C@H]2O)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)C)(C)CC1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O YURJSTAIMNSZAE-HHNZYBFYSA-N 0.000 claims description 9
- CBEHEBUBNAGGKC-UHFFFAOYSA-N ginsenoside Rg1 Natural products CC(=CCCC(C)(OC1OC(CO)C(O)C(O)C1O)C2CCC3(C)C2C(O)CC4C5(C)CCC(O)C(C)(C)C5CC(OC6OC(CO)C(O)C(O)C6O)C34C)C CBEHEBUBNAGGKC-UHFFFAOYSA-N 0.000 claims description 9
- AOGZLQUEBLOQCI-UHFFFAOYSA-N ginsenoside-Re Natural products CC1OC(OCC2OC(OC3CC4(C)C(CC(O)C5C(CCC45C)C(C)(CCC=C(C)C)OC6OC(CO)C(O)C(O)C6O)C7(C)CCC(O)C(C)(C)C37)C(O)C(O)C2O)C(O)C(O)C1O AOGZLQUEBLOQCI-UHFFFAOYSA-N 0.000 claims description 9
- NTDLXWMIWOECHG-YRCFQSNFSA-N apiin Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O)[C@H]1O[C@H]1[C@@H]([C@@](O)(CO)CO1)O)O)CO)C(C=1)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C=C1 NTDLXWMIWOECHG-YRCFQSNFSA-N 0.000 claims description 8
- 239000012088 reference solution Substances 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 241001061264 Astragalus Species 0.000 claims description 7
- 235000006533 astragalus Nutrition 0.000 claims description 7
- 238000010828 elution Methods 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 7
- 210000004233 talus Anatomy 0.000 claims description 7
- 239000009636 Huang Qi Substances 0.000 claims description 6
- 235000011477 liquorice Nutrition 0.000 claims description 6
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 claims description 5
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 claims description 5
- FURUXTVZLHCCNA-UHFFFAOYSA-N Liquiritigenin Natural products C1=CC(O)=CC=C1C1OC2=CC(O)=CC=C2C(=O)C1 FURUXTVZLHCCNA-UHFFFAOYSA-N 0.000 claims description 5
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 5
- 229930016911 cinnamic acid Natural products 0.000 claims description 5
- 235000013985 cinnamic acid Nutrition 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- RIKPNWPEMPODJD-UHFFFAOYSA-N formononetin Natural products C1=CC(OC)=CC=C1C1=COC2=CC=CC=C2C1=O RIKPNWPEMPODJD-UHFFFAOYSA-N 0.000 claims description 5
- NLDDIKRKFXEWBK-AWEZNQCLSA-N gingerol Chemical group CCCCC[C@H](O)CC(=O)CCC1=CC=C(O)C(OC)=C1 NLDDIKRKFXEWBK-AWEZNQCLSA-N 0.000 claims description 5
- JZLXEKNVCWMYHI-UHFFFAOYSA-N gingerol Natural products CCCCC(O)CC(=O)CCC1=CC=C(O)C(OC)=C1 JZLXEKNVCWMYHI-UHFFFAOYSA-N 0.000 claims description 5
- JBQATDIMBVLPRB-UHFFFAOYSA-N isoliquiritigenin Natural products OC1=CC(O)=CC=C1C1OC2=CC(O)=CC=C2C(=O)C1 JBQATDIMBVLPRB-UHFFFAOYSA-N 0.000 claims description 5
- FURUXTVZLHCCNA-AWEZNQCLSA-N liquiritigenin Chemical compound C1=CC(O)=CC=C1[C@H]1OC2=CC(O)=CC=C2C(=O)C1 FURUXTVZLHCCNA-AWEZNQCLSA-N 0.000 claims description 5
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 claims description 5
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims description 4
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims description 4
- 229940010454 licorice Drugs 0.000 claims description 4
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical group [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 claims description 3
- 239000002245 particle Substances 0.000 claims description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 2
- 238000000227 grinding Methods 0.000 claims description 2
- 239000000741 silica gel Substances 0.000 claims description 2
- 229910002027 silica gel Inorganic materials 0.000 claims description 2
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- 244000131316 Panax pseudoginseng Species 0.000 claims 1
- 244000273928 Zingiber officinale Species 0.000 claims 1
- 239000000796 flavoring agent Substances 0.000 abstract description 6
- 238000003908 quality control method Methods 0.000 abstract description 6
- 235000019634 flavors Nutrition 0.000 abstract description 5
- 230000035945 sensitivity Effects 0.000 abstract description 2
- 238000013441 quality evaluation Methods 0.000 abstract 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 21
- 239000000523 sample Substances 0.000 description 13
- 241000234314 Zingiber Species 0.000 description 10
- 239000012085 test solution Substances 0.000 description 10
- 241000208340 Araliaceae Species 0.000 description 9
- 239000000843 powder Substances 0.000 description 9
- 235000014347 soups Nutrition 0.000 description 9
- 238000005303 weighing Methods 0.000 description 7
- 239000008176 lyophilized powder Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 230000009471 action Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- AVGPOAXYRRIZMM-UHFFFAOYSA-N D-Apiose Natural products OCC(O)(CO)C(O)C=O AVGPOAXYRRIZMM-UHFFFAOYSA-N 0.000 description 2
- ASNHGEVAWNWCRQ-LJJLCWGRSA-N D-apiofuranose Chemical compound OC[C@@]1(O)COC(O)[C@@H]1O ASNHGEVAWNWCRQ-LJJLCWGRSA-N 0.000 description 2
- ASNHGEVAWNWCRQ-UHFFFAOYSA-N D-apiofuranose Natural products OCC1(O)COC(O)C1O ASNHGEVAWNWCRQ-UHFFFAOYSA-N 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000012490 blank solution Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 229940126680 traditional chinese medicines Drugs 0.000 description 2
- 208000032467 Aplastic anaemia Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 235000017443 Hedysarum boreale Nutrition 0.000 description 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 1
- 208000019914 Mental Fatigue Diseases 0.000 description 1
- CWEZAWNPTYBADX-UHFFFAOYSA-N Procyanidin Natural products OC1C(OC2C(O)C(Oc3c2c(O)cc(O)c3C4C(O)C(Oc5cc(O)cc(O)c45)c6ccc(O)c(O)c6)c7ccc(O)c(O)c7)c8c(O)cc(O)cc8OC1c9ccc(O)c(O)c9 CWEZAWNPTYBADX-UHFFFAOYSA-N 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 229940107666 astragalus root Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 208000020832 chronic kidney disease Diseases 0.000 description 1
- 208000022831 chronic renal failure syndrome Diseases 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000000105 evaporative light scattering detection Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 229920002414 procyanidin Polymers 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000002390 rotary evaporation Methods 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/86—Signal analysis
- G01N30/8675—Evaluation, i.e. decoding of the signal into analytical information
- G01N30/8686—Fingerprinting, e.g. without prior knowledge of the sample components
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/86—Signal analysis
- G01N30/8675—Evaluation, i.e. decoding of the signal into analytical information
- G01N30/8679—Target compound analysis, i.e. whereby a limited number of peaks is analysed
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N2030/022—Column chromatography characterised by the kind of separation mechanism
- G01N2030/027—Liquid chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
- G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
Landscapes
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Library & Information Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110140726.5A CN112903882B (zh) | 2021-02-02 | 2021-02-02 | 一种保元汤制剂的hplc特征图谱及其构建方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110140726.5A CN112903882B (zh) | 2021-02-02 | 2021-02-02 | 一种保元汤制剂的hplc特征图谱及其构建方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112903882A true CN112903882A (zh) | 2021-06-04 |
CN112903882B CN112903882B (zh) | 2024-07-09 |
Family
ID=76121205
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110140726.5A Active CN112903882B (zh) | 2021-02-02 | 2021-02-02 | 一种保元汤制剂的hplc特征图谱及其构建方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112903882B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113899835A (zh) * | 2021-12-13 | 2022-01-07 | 江西中医药大学 | 一种同时检测保元汤制剂中多种指标性成分的方法 |
CN114184719A (zh) * | 2021-12-13 | 2022-03-15 | 江西和盈药业有限公司 | 一种保元汤的双波长指纹图谱建立方法及其标准指纹图谱 |
CN115166066A (zh) * | 2022-05-27 | 2022-10-11 | 陕西中医药大学 | 芪珠升白口服液的质量评价方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106501434A (zh) * | 2016-12-30 | 2017-03-15 | 天津同仁堂集团股份有限公司 | 一种双和汤标准汤的hplc指纹图谱测定方法 |
CN110455965A (zh) * | 2019-08-21 | 2019-11-15 | 劲牌生物医药有限公司 | 药物组合物的制备方法及其hplc指纹图谱建立方法 |
CN110907580A (zh) * | 2019-12-20 | 2020-03-24 | 东阿阿胶股份有限公司 | 一种保元汤的hplc特征图谱的检测方法 |
CN111443142A (zh) * | 2020-04-24 | 2020-07-24 | 河北神威药业有限公司 | 一种保元汤制剂中多指标成分的同时检测方法 |
CN111487343A (zh) * | 2020-04-24 | 2020-08-04 | 河北神威药业有限公司 | 一种保元汤制剂指纹图谱的建立方法 |
CN111905084A (zh) * | 2020-08-07 | 2020-11-10 | 浙江金城阜通制药有限公司 | 一种中药提取物及其制备工艺及其应用 |
-
2021
- 2021-02-02 CN CN202110140726.5A patent/CN112903882B/zh active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106501434A (zh) * | 2016-12-30 | 2017-03-15 | 天津同仁堂集团股份有限公司 | 一种双和汤标准汤的hplc指纹图谱测定方法 |
CN110455965A (zh) * | 2019-08-21 | 2019-11-15 | 劲牌生物医药有限公司 | 药物组合物的制备方法及其hplc指纹图谱建立方法 |
CN110907580A (zh) * | 2019-12-20 | 2020-03-24 | 东阿阿胶股份有限公司 | 一种保元汤的hplc特征图谱的检测方法 |
CN111443142A (zh) * | 2020-04-24 | 2020-07-24 | 河北神威药业有限公司 | 一种保元汤制剂中多指标成分的同时检测方法 |
CN111487343A (zh) * | 2020-04-24 | 2020-08-04 | 河北神威药业有限公司 | 一种保元汤制剂指纹图谱的建立方法 |
CN111905084A (zh) * | 2020-08-07 | 2020-11-10 | 浙江金城阜通制药有限公司 | 一种中药提取物及其制备工艺及其应用 |
Non-Patent Citations (1)
Title |
---|
杨净尧: "经典名方保元汤的物质基准研究", 《中国优秀硕士学位论文全文数据库(医药卫生科技辑)》, no. 12, 31 December 2020 (2020-12-31), pages 057 - 14 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113899835A (zh) * | 2021-12-13 | 2022-01-07 | 江西中医药大学 | 一种同时检测保元汤制剂中多种指标性成分的方法 |
CN114184719A (zh) * | 2021-12-13 | 2022-03-15 | 江西和盈药业有限公司 | 一种保元汤的双波长指纹图谱建立方法及其标准指纹图谱 |
CN114184719B (zh) * | 2021-12-13 | 2023-05-09 | 江西和盈药业有限公司 | 一种保元汤的双波长指纹图谱建立方法及其标准指纹图谱 |
CN115166066A (zh) * | 2022-05-27 | 2022-10-11 | 陕西中医药大学 | 芪珠升白口服液的质量评价方法 |
CN115166066B (zh) * | 2022-05-27 | 2023-11-03 | 陕西中医药大学 | 芪珠升白口服液的质量评价方法 |
Also Published As
Publication number | Publication date |
---|---|
CN112903882B (zh) | 2024-07-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112903882A (zh) | 一种保元汤制剂的hplc特征图谱及其构建方法 | |
CN105806975B (zh) | 一种银翘散uplc指纹图谱的建立方法 | |
CN110455965A (zh) | 药物组合物的制备方法及其hplc指纹图谱建立方法 | |
CN111487343B (zh) | 一种保元汤制剂指纹图谱的建立方法 | |
CN101766771A (zh) | 一种治疗妇科疾病药物的质量控制方法 | |
CN101991661A (zh) | 含白芍、人参、丹参、青蒿、甘草、川芎和当归中至少两种的中成药的检测方法 | |
CN106442789A (zh) | 复方血脂宁提取物指纹图谱的建立及其活性成分定量分析方法 | |
CN106226440A (zh) | 升麻葛根汤组合物的质量控制方法 | |
CN110672747A (zh) | 淫羊藿成分的检测方法和鉴别淫羊藿品种的方法及应用 | |
CN105911161B (zh) | 一种消炎片hplc指纹图谱构建方法 | |
CN113156001A (zh) | 一种包含当归的中药复方的指纹图谱构建方法及其应用 | |
CN103285306B (zh) | 益气补肾的中药组合物的制备方法及检测方法 | |
CN113063885B (zh) | 用于制备保元汤的组合物,保元汤制品,及其指纹图谱测定和质量检测方法 | |
CN113281439B (zh) | 肾宝片的质量控制检测方法 | |
CN110824068A (zh) | 一种鸢都感冒颗粒指纹图谱的建立方法及应用 | |
CN113376273B (zh) | 一种清心莲子饮hplc特征图谱的检测方法及该特征图谱的应用 | |
CN114280209A (zh) | 一种小儿清热止咳口服液指纹图谱的建立方法及其指纹图谱 | |
CN112285241A (zh) | 一种沙参麦冬汤的hplc指纹图谱的构建方法 | |
CN100372563C (zh) | 治疗支气管炎的复方制剂及其制备方法、质量控制方法 | |
CN110487942B (zh) | 一种抗抑郁药物的指纹图谱检测方法 | |
CN106526000B (zh) | 升麻葛根汤组合物指纹图谱的建立方法及指纹图谱 | |
CN108226325A (zh) | 葶苈生脉口服液组合物指纹图谱的建立方法 | |
CN101411836A (zh) | 一种治疗感冒后咳嗽的中药制剂质量标准及其检验方法 | |
CN107894466B (zh) | 一种金桑芪抗毒制剂hplc指纹图谱的测定方法及金桑芪抗毒制剂质量控制方法 | |
CN112763639A (zh) | 刺五加对照提取物的制备工艺及其质量控制方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20240605 Address after: 611135, 6th Floor, Building 10, No. 733, Section 2, Furong Avenue, Chengdu Cross Strait Science and Technology Industrial Development Park, Wenjiang District, Chengdu City, Sichuan Province Applicant after: Sichuan Puhua traditional Chinese Medicine Technology Co.,Ltd. Country or region after: China Address before: No. 505, building 6, Zone D, Tianfu Software Park, No. 599, shijicheng South Road, Chengdu hi tech Zone, China (Sichuan) pilot Free Trade Zone, Chengdu, Sichuan 610041 Applicant before: CHENGDU BRIGHT BIOLOGICAL TECHNOLOGY Co.,Ltd. Country or region before: China |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant |